Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

BNGO - Bionano Genomics Inc


IEX Last Trade
0.4897
0.007   1.327%

Share volume: 753,150
Last Updated: Fri 30 Aug 2024 09:58:01 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%

$0.48
0.01
1.35%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
20%
Profitability 8%
Dept financing 11%
Liquidity 75%
Performance 20%
Company vs Stock growth
vs
Performance
5 Days
-6.83%
1 Month
-22.02%
3 Months
-49.60%
6 Months
-61.42%
1 Year
-86.61%
2 Year
-97.98%
Key data
Stock price
$0.49
P/E Ratio 
-0.21
DAY RANGE
N/A - $0.49
EPS 
-$4.18
52 WEEK RANGE
$0.31 - $3.86
52 WEEK CHANGE
-$0.87
MARKET CAP 
42.139 M
YIELD 
N/A
SHARES OUTSTANDING 
85.997 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
BETA 
2.73
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$956,308
AVERAGE 30 VOLUME 
$2,127,449
Company detail
CEO: R. Erik Holmlin
Region: US
Website: https://bionanogenomics.com/
Employees: 313
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

at bionano genomics®, we are committed to unlocking understanding of genome biology to advance the promise of genomics in areas including cancer and human disease, agricultural bioengineering and genome discovery. our team is not afraid to venture into uncharted territory to look for answers. we welcome the curious and provide a place where those who are not satisfied with the status quo can feel at home. our next-generation genome mapping and analysis tools help researchers see true genome structure to fill in what’s missing from sequencing-based data. saphyr™, our high-speed, high-throughput whole genome mapping solution, offers unmatched structural variation discovery capabilities and the ability to construct the most complete genome assemblies. at bionano, we are invested in the success of our customers and users around the world, and are dedicated to supporting them with the tools, resources and support they need to achieve their goals and make a real impact on improving quality o

Recent news